CELZCREATIVE MEDICAL TECHNOLOGY...

Nasdaq creativemedicaltechnology.com


$ 4.33 $ -0.04 (-0.9 %)    

Tuesday, 14-May-2024 10:53:14 EDT
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 4.4
$ 4.33
$ 0.00 x 0
$ 0.00 x 0
$ 4.33 - $ 4.33
$ 3.93 - $ 10.28
1,692
na
5.93M
$ 6.19
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-22-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-30-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-17-2021 12-31-2020 10-K
15 11-13-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 04-06-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 05-20-2019 03-31-2019 10-Q
22 04-01-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 05-21-2018 03-31-2018 10-Q
26 03-29-2018 12-31-2017 10-K
27 11-13-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 02-13-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-19-2016 06-30-2016 10-Q
33 05-13-2016 03-31-2016 10-Q
34 04-14-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-13-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-12-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-highpeak-energy-shares-are-trading-lower-by-15-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-exp...

 why-is-diabetes-focused-creative-medical-stock-surging-on-thursday

FDA approval under expanded access for Creative Medical. CELZ-201, a pioneering cell-based program, targets abnormal glucose to...

 creative-medical-technology-holdings-inc-announces-fda-authorization-for-groundbreaking-type-1-diabetes-prevention-therapy-under-expanded-access

Creative Medical Technology Holdings, Inc., (NASDAQ:CELZ), a leader in biotech innovation, today announced a major stride in co...

Core News & Articles
Market-Moving News for March 6th
03/06/2024 13:33:37

CRWD: 27% | CrowdStrike Holdings shares are trading higher after the company reported better-than-expected Q4 earnings and reve...

 creative-medical-technology-receives-fda-orphan-drug-designation-for-celz-101-in-key-transplantation-therapy

This cutting-edge therapy is aimed at preventing allograft rejection in patients undergoing pancreatic islet cell transplantati...

 creative-medical-technologies-filed-us-patent-application-20240002792-repair-of-ovarian-damage-and-dampening-of-inflammatory-microenvironment-by-administration-of-monocytic-granulocytic-progenitors-with-immune-modulatory-activities

https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240002792

 creative-medical-technologies-filed-us-patent-application--20230407254---inducible-pluripotent-stem-cell-derived-regenerative-t-cells

https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20230407254

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION